Evidence map›Paper›PMID 31419367›Full record

ArticleAngewandte Chemie (International ed. in English)2019

Total Syntheses of Xiamycins A, C, F, H and Oridamycin A and Preliminary Evaluation of their Anti-Fungal Properties.

Magnus Pfaffenbach, Ian Bakanas, Nicholas R O'Connor, Jessica L Herrick, Richmond Sarpong

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Oxodealkenylative Cleavage of Alkene C(spAngewandte Chemie (International ed. in English) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Magnus PfaffenbachDepartment of Chemistry, University of California, Berkeley, CA, 94720, USA.
Ian BakanasDepartment of Chemistry, University of California, Berkeley, CA, 94720, USA.
Nicholas R O'ConnorDepartment of Chemistry, University of California, Berkeley, CA, 94720, USA.
Jessica L HerrickCorteva Agriscience, Crop Protection Discovery, Zionsville, IN, 46077, USA.
Richmond SarpongDepartment of Chemistry, University of California, Berkeley, CA, 94720, USA.ORCID 0000-0002-0028-6323

Funding

Strategies and Methods for Complex Molecule Synthesis: Acquisition of a 400 MHz Nuclear Magnetic Resonance Spectrometer ConsoleR35GM130345 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Richmond Sarpong · 2019 to 2026
$5.4M
NIGMS NIH HHS R35 GM130345
6 · The paper itself

Abstract

Divergent and enantiospecific total syntheses of the indolosesquiterpenoids xiamycins A, C, F, H and oridamycin A have been accomplished. The syntheses, which commence from (R)-carvone, employ a key photoinduced benzannulation sequence to forge the carbazole moiety characteristic of these natural products. Late-stage diversification from a common intermediate enabled the first syntheses of xiamycins C and F, and an unexpected one-pot oxidative decarboxylation, which may prove general, led to xiamycin H. All synthetic intermediates and the natural products were tested for anti-fungal activity. Xiamycin H emerged as an inhibitor of three agriculturally relevant fungal pathogens.

Indexed as

LightAntifungal AgentsCyclizationCyclohexane MonoterpenesDecarboxylationMitosporic FungiOxidation-ReductionSesquiterpenesStereoisomerismUstilagoAntifungal AgentscarvoneCyclohexane Monoterpenesoridamycin ASesquiterpenesxiamycinxiamycin Cbenzannulationchiral pooldivergent synthesisfungitoxicitytotal synthesis

Identifiers

PMID31419367
PMCPMC6791741

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.